Eurofins Scientific SE
PAR:ERF

Watchlist Manager
Eurofins Scientific SE Logo
Eurofins Scientific SE
PAR:ERF
Watchlist
Price: 46.96 EUR 1.29% Market Closed
Market Cap: 9B EUR
Have any thoughts about
Eurofins Scientific SE?
Write Note

Intrinsic Value

The intrinsic value of one ERF stock under the Base Case scenario is 78.3 EUR. Compared to the current market price of 46.96 EUR, Eurofins Scientific SE is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ERF Intrinsic Value
78.3 EUR
Undervaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Eurofins Scientific SE

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ERF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ERF?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Eurofins Scientific SE

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Eurofins Scientific SE

Provide an overview of the primary business activities
of Eurofins Scientific SE.

What unique competitive advantages
does Eurofins Scientific SE hold over its rivals?

What risks and challenges
does Eurofins Scientific SE face in the near future?

Summarize the latest earnings call
of Eurofins Scientific SE.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Eurofins Scientific SE.

Provide P/S
for Eurofins Scientific SE.

Provide P/E
for Eurofins Scientific SE.

Provide P/OCF
for Eurofins Scientific SE.

Provide P/FCFE
for Eurofins Scientific SE.

Provide P/B
for Eurofins Scientific SE.

Provide EV/S
for Eurofins Scientific SE.

Provide EV/GP
for Eurofins Scientific SE.

Provide EV/EBITDA
for Eurofins Scientific SE.

Provide EV/EBIT
for Eurofins Scientific SE.

Provide EV/OCF
for Eurofins Scientific SE.

Provide EV/FCFF
for Eurofins Scientific SE.

Provide EV/IC
for Eurofins Scientific SE.

Show me price targets
for Eurofins Scientific SE made by professional analysts.

What are the Revenue projections
for Eurofins Scientific SE?

How accurate were the past Revenue estimates
for Eurofins Scientific SE?

What are the Net Income projections
for Eurofins Scientific SE?

How accurate were the past Net Income estimates
for Eurofins Scientific SE?

What are the EPS projections
for Eurofins Scientific SE?

How accurate were the past EPS estimates
for Eurofins Scientific SE?

What are the EBIT projections
for Eurofins Scientific SE?

How accurate were the past EBIT estimates
for Eurofins Scientific SE?

Compare the revenue forecasts
for Eurofins Scientific SE with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Eurofins Scientific SE and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Eurofins Scientific SE against its competitors.

Analyze the profit margins
(gross, operating, and net) of Eurofins Scientific SE compared to its peers.

Compare the P/E ratios
of Eurofins Scientific SE against its peers.

Discuss the investment returns and shareholder value creation
comparing Eurofins Scientific SE with its peers.

Analyze the financial leverage
of Eurofins Scientific SE compared to its main competitors.

Show all profitability ratios
for Eurofins Scientific SE.

Provide ROE
for Eurofins Scientific SE.

Provide ROA
for Eurofins Scientific SE.

Provide ROIC
for Eurofins Scientific SE.

Provide ROCE
for Eurofins Scientific SE.

Provide Gross Margin
for Eurofins Scientific SE.

Provide Operating Margin
for Eurofins Scientific SE.

Provide Net Margin
for Eurofins Scientific SE.

Provide FCF Margin
for Eurofins Scientific SE.

Show all solvency ratios
for Eurofins Scientific SE.

Provide D/E Ratio
for Eurofins Scientific SE.

Provide D/A Ratio
for Eurofins Scientific SE.

Provide Interest Coverage Ratio
for Eurofins Scientific SE.

Provide Altman Z-Score Ratio
for Eurofins Scientific SE.

Provide Quick Ratio
for Eurofins Scientific SE.

Provide Current Ratio
for Eurofins Scientific SE.

Provide Cash Ratio
for Eurofins Scientific SE.

What is the historical Revenue growth
over the last 5 years for Eurofins Scientific SE?

What is the historical Net Income growth
over the last 5 years for Eurofins Scientific SE?

What is the current Free Cash Flow
of Eurofins Scientific SE?

Discuss the annual earnings per share (EPS)
trend over the past five years for Eurofins Scientific SE.

Business Breakdown

Eurofins Scientific SE is a global leader in bio-analytical testing, offering a broad array of laboratory services that cater to a variety of sectors including food, pharmaceuticals, environmental, and consumer products. Founded in 1987, the company has expanded rapidly through strategic acquisitions and organic growth, positioning itself as a crucial partner for businesses aiming to ensure quality and compliance in their products. With its presence in over 50 countries and a workforce exceeding 50,000, Eurofins operates a network of highly specialized laboratories that leverage cutting-edge technology to deliver accurate, reliable testing services. Investors will appreciate the company’s ro...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eurofins Scientific SE

Current Assets 3.1B
Cash & Short-Term Investments 472.1m
Receivables 1.6B
Other Current Assets 977.3m
Non-Current Assets 7.8B
Long-Term Investments 83.6m
PP&E 2.3B
Intangibles 5.3B
Other Non-Current Assets 93.8m
Current Liabilities 2.1B
Accounts Payable 339.2m
Accrued Liabilities 320.2m
Short-Term Debt 200k
Other Current Liabilities 1.5B
Non-Current Liabilities 3.7B
Long-Term Debt 3.3B
Other Non-Current Liabilities 363.8m
Efficiency

Earnings Waterfall
Eurofins Scientific SE

Revenue
6.7B EUR
Cost of Revenue
-5.2B EUR
Gross Profit
1.5B EUR
Operating Expenses
-538.3m EUR
Operating Income
942.4m EUR
Other Expenses
-616.5m EUR
Net Income
325.9m EUR

Free Cash Flow Analysis
Eurofins Scientific SE

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Eurofins delivered a positive third-quarter performance despite the reduction in COVID-related revenue that boosted 2021 figures. The comparison is now more normalized ('apples to apples'), and the outlook appears favorable, particularly in non-COVID areas like America and biopharma product testing. Challenges remain, especially in earlier biopharma phases and the European market, influenced by economic headwinds and consumer inflation impact. Nevertheless, Eurofins is showing resilience, with Asia indicating some areas of misclassified revenues. Strategic M&A activity continues with disciplined investment, aiming for EUR 250 million pro forma revenues. R&D investment persists, amplifying the role of AI across different segments. Revenue guidance remains in a range, due to currency uncertainties, and the company maintains its objective of 6.5% organic growth.

What is Earnings Call?
Fundamental Scores

ERF Profitability Score
Profitability Due Diligence

Eurofins Scientific SE's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive Operating Income
Positive Revenue Growth Forecast
51/100
Profitability
Score

Eurofins Scientific SE's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

ERF Solvency Score
Solvency Due Diligence

Eurofins Scientific SE's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
50/100
Solvency
Score

Eurofins Scientific SE's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ERF Price Targets Summary
Eurofins Scientific SE

Wall Street analysts forecast ERF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ERF is 60.34 EUR with a low forecast of 42.42 EUR and a high forecast of 93.45 EUR.

Lowest
Price Target
42.42 EUR
10% Downside
Average
Price Target
60.34 EUR
28% Upside
Highest
Price Target
93.45 EUR
99% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ERF?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ERF is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Eurofins Scientific SE Logo
Eurofins Scientific SE

Country

Luxembourg

Industry

Life Sciences Tools & Services

Market Cap

9B EUR

Dividend Yield

1.06%

Description

Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. The company operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.

Contact

Luxembourg
23 Val Fleuri
+35226185320.0
www.eurofins.com

IPO

1997-10-24

Employees

57 992

Officers

Chairman of the Board & CEO
Dr. Gilles G. Martin Ph.D.
Executive Director
Ms. Valerie Hanote
Group Administration & CFO
Mr. Laurent Lebras
Head of Investor Relations
Mr. Bernard Wang
Chief Human Resources Officer
Ms. Sandra Hoeylaerts
Senior VP of Strategic Business Development North America
Mr. David W. Bryant
Show More
Senior VP of Clinical Diagnostics Europe
Mr. Gabriel Julia
Executive VP of BioPharma, Genomics & Agrosciences Services North America
Dr. Timothy S. Oostdyk
Senior Vice President of Food & Feed Testing Europe
Mr. Joachim Reichelt
Senior Vice President of Environment Testing Europe
Ms. Yvoine Remy
Show Less

See Also

Discover More
What is the Intrinsic Value of one ERF stock?

The intrinsic value of one ERF stock under the Base Case scenario is 78.3 EUR.

Is ERF stock undervalued or overvalued?

Compared to the current market price of 46.96 EUR, Eurofins Scientific SE is Undervalued by 40%.

Back to Top